Tikva Allocell Pte Ltd
Ari Loren currently holds a position as the Chief Operating Officer and Co-Founder at Tikva Allocell Pte Ltd. Prior to this, Ari has had significant experience as an Executive Vice President at Bronx Park Rehabilitation, as an Owner at Blueshirt Properties and DAG Holdings, and as a Founder at Debt Acquisition Group. Ari also has experience as an Asset Manager at Glacier Global Partners, Director of Operations at CI-Lumen Industries, and Administrator at BHCC. Ari holds an MBA from Bar-Ilan University and a BS in Management from Yeshiva University.
This person is not in any teams
This person is not in any offices
Tikva Allocell Pte Ltd
Tikva Allocell is a cell therapy company focused on a Second Generation Allogeneic EBV-Specific T cell (ALLO EBVST) platform to target difficult-to-treat cancers. At Tikva Allocell, our mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by leveraging excellent safety profile of ALLO EBVST and proprietary technologies that enhance the T cell's performance to treat cancer.